Clinical TrailsRoche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Roche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Read Post »
Clinical TrailsAtacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Atacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Read Post »
Clinical TrailsEli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Eli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Read Post »
Clinical TrailsRoche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Roche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Read Post »
Clinical TrailsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... Read Post »
Clinical TrailsGefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Gefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Read Post »
Clinical TrailsNovartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Novartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Read Post »
Clinical TrailsBridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... BridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... Read Post »
Clinical TrailsIntellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Intellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Read Post »
Clinical TrailsSanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Sanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Read Post »
Clinical TrailsInnovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Innovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Read Post »
Clinical TrailsLong-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Long-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Read Post »
Clinical TrailsNipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Nipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Read Post »
Clinical TrailsAlector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Alector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Read Post »
Clinical TrailsModerna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Moderna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Read Post »
Clinical Trails ResearchFirst Successful Restoration of Central Vision in Dry AMD Using Subretinal ... First Successful Restoration of Central Vision in Dry AMD Using Subretinal ... Read Post »
Clinical TrailsNovo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Novo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Read Post »
Clinical TrailsHigher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Higher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Read Post »
Clinical TrailsFDA Approves Early Use of RINVOQ before TNF Blockers for Select IBD Patient... FDA Approves Early Use of RINVOQ before TNF Blockers for Select IBD Patient... Read Post »
Clinical Trails Drugs Safety AlertFDA Flags New Safety Risk for Carvykti: Immune Effector Cell Associated Ent... FDA Flags New Safety Risk for Carvykti: Immune Effector Cell Associated Ent... Read Post »
Clinical TrailsRegeneron’s DB-OTO Gene Therapy Shows Breakthrough Hearing Restoration in... Regeneron’s DB-OTO Gene Therapy Shows Breakthrough Hearing Restoration in... Read Post »
Clinical Trails36-Month Phase I Results Highlight Bemdaneprocel Stem Cell Therapy Promise ... 36-Month Phase I Results Highlight Bemdaneprocel Stem Cell Therapy Promise ... Read Post »
Clinical TrailsNeflamapimod Delivers Clinical and Biomarker Benefits in Dementia with Lewy... Neflamapimod Delivers Clinical and Biomarker Benefits in Dementia with Lewy... Read Post »
Clinical TrailsValbenazine from KINECT-PRO Study Delivers Superior Well-Being Results for ... Valbenazine from KINECT-PRO Study Delivers Superior Well-Being Results for ... Read Post »
Clinical Trails Health TidingsWHO Launches Global Clinical Trials Forum to Boost Worldwide Health Researc... WHO Launches Global Clinical Trials Forum to Boost Worldwide Health Researc... Read Post »
Clinical Trails New Drug ApprovalFDA Approves Arcutis’ Zoryve (Roflumilast) Cream 0.05% for Mild to Modera... FDA Approves Arcutis’ Zoryve (Roflumilast) Cream 0.05% for Mild to Modera... Read Post »
Clinical TrailsFDA Fast Tracks ETX‑636: New Hope for PIK3CA-Mutant Advanced Breast Cance... FDA Fast Tracks ETX‑636: New Hope for PIK3CA-Mutant Advanced Breast Cance... Read Post »
Clinical TrailsPositive Phase 2b Results of Enanta’s Zelicapavir in High-Risk Adults wit... Positive Phase 2b Results of Enanta’s Zelicapavir in High-Risk Adults wit... Read Post »
Clinical Trails New Drug ApprovalIntroducing Ozempic in India: A Breakthrough in Type 2 Diabetes and Weight ... Introducing Ozempic in India: A Breakthrough in Type 2 Diabetes and Weight ... Read Post »
Clinical Trails New Drug ApprovalFDA Approves Jazz’s Zepzelca plus Roche’s Tecentriq for Extensive-S... FDA Approves Jazz’s Zepzelca plus Roche’s Tecentriq for Extensive-S... Read Post »
Clinical Trails New Drug ApprovalFDA Approval of Rhapsido® (remibrutinib) for Chronic Spontaneous Urticaria... FDA Approval of Rhapsido® (remibrutinib) for Chronic Spontaneous Urticaria... Read Post »
Clinical TrailsIonis’ Zilganersen Sets New Milestone in Alexander Disease with Phase 3 R... Ionis’ Zilganersen Sets New Milestone in Alexander Disease with Phase 3 R... Read Post »
Clinical TrailsJ&J‘s Investigational Seltorexant: Comparable to Quetiapine in Depre... J&J‘s Investigational Seltorexant: Comparable to Quetiapine in Depre... Read Post »
Clinical TrailsSotatercept Shows Early Benefit in Pulmonary Arterial Hypertension When Add... Sotatercept Shows Early Benefit in Pulmonary Arterial Hypertension When Add... Read Post »
Clinical TrailsFirst-in-Human Gene Therapy AMT-130 for Huntington’s disease Reports Posi... First-in-Human Gene Therapy AMT-130 for Huntington’s disease Reports Posi... Read Post »
Clinical Trails New Drug ApprovalFDA approves Palsonify (paltusotine) a once-daily oral option for adults wi... FDA approves Palsonify (paltusotine) a once-daily oral option for adults wi... Read Post »
Clinical Trails New Drug ApprovalFDA Authorizes Essilor Stellest™ Lenses to Slow Childhood Myopia FDA Authorizes Essilor Stellest™ Lenses to Slow Childhood Myopia Read Post »
Clinical Trails New Drug ApprovalFDA Approves Inluriyo for ESR1-Mutated Advanced Breast Cancer FDA Approves Inluriyo for ESR1-Mutated Advanced Breast Cancer Read Post »
Clinical Trails“Permethrin-Treated Baby Wraps Against Malaria” “Permethrin-Treated Baby Wraps Against Malaria” Read Post »
Clinical TrailsCan oral Semaglutide (Wegovy) 25 mg replace the Once-Weekly 2.4 mg Injectio... Can oral Semaglutide (Wegovy) 25 mg replace the Once-Weekly 2.4 mg Injectio... Read Post »
Clinical TrailsRoche’s Phase 3 evERA Trial: Giredestrant Boosts Progression-Free Surviva... Roche’s Phase 3 evERA Trial: Giredestrant Boosts Progression-Free Surviva... Read Post »
Clinical TrailsNovo Nordisk’s Cagrilintide shows promising weight loss in REDEFINE-1... Novo Nordisk’s Cagrilintide shows promising weight loss in REDEFINE-1... Read Post »
Clinical Trails Lifestyle7,000 vs. 10,000 Steps: How Daily Walking Protects Against Death, Heart Dis... 7,000 vs. 10,000 Steps: How Daily Walking Protects Against Death, Heart Dis... Read Post »
Clinical TrailsBaxdrostat Brings Hope for Patients with Resistant and Uncontrolled Hyperte... Baxdrostat Brings Hope for Patients with Resistant and Uncontrolled Hyperte... Read Post »
Clinical TrailsNovo Nordisk’s Wegovy (Semaglutide) Reduces Cardiovascular Event Risk... Novo Nordisk’s Wegovy (Semaglutide) Reduces Cardiovascular Event Risk... Read Post »
Clinical TrailsFDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after T... FDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after T... Read Post »
Clinical TrailsLorundrostat Achieves Significant Blood Pressure Reductions in Phase 3 Laun... Lorundrostat Achieves Significant Blood Pressure Reductions in Phase 3 Laun... Read Post »
Clinical TrailsAmgen’s Once-Monthly Maridebart cafraglutide (MariTide) Demonstrates ... Amgen’s Once-Monthly Maridebart cafraglutide (MariTide) Demonstrates ... Read Post »
Clinical Trails“CagriSema: A Powerful New Weight Loss and Diabetes Combination Therapy E... “CagriSema: A Powerful New Weight Loss and Diabetes Combination Therapy E... Read Post »
Clinical TrailsIbezapolstat: AcurX Pharmaceuticals First-in-Class Mechanism Antibiotic for... Ibezapolstat: AcurX Pharmaceuticals First-in-Class Mechanism Antibiotic for... Read Post »
